An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film...
Cooper University Hospital, Camden, New Jersey, United States
Johns Hopkins Hospital, Baltimore, Maryland, United States
The Ohio State University, Columbus, Ohio, United States
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
The University of Texas Southwestern MedicalCenter at Dallas, Dallas, Texas, United States
Brigham and Women's Hospital, Boston, Massachusetts, United States
Memorial Hermann Hospital, Houston, Texas, United States
Baylor University Medical Center - Department of Anesthesiology, Dallas, Texas, United States
Univ of Texas Southwestern Medical Center, Dallas, Texas, United States
Cleveland Clinic, Cleveland, Ohio, United States
Outcomes Research Institute, University of Louisville, Louisville, Kentucky, United States
Duke University Medical Center, Durham, North Carolina, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.